Sprint Bioscience AB (publ) (STO:SPRINT)

Sprint Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	203	155	110	121	22	191
Market Cap Growth	90.39%	40.43%	-8.82%	449.78%	-88.47%	17.26%
Enterprise Value	76	144	79	66	-5	105
Last Close Price	1.92	1.47	1.56	1.71	0.54	4.72
PE Ratio	1.96	1.69	-	-	-	-
Forward PE	6.40	-	-	-	-	-
PS Ratio	1.21	0.93	1.67	2.34	265.47	5.45
PB Ratio	1.70	1.30	11.91	4.36	0.78	2.71
P/TBV Ratio	1.70	1.30	11.91	4.36	0.78	2.71
P/FCF Ratio	2.43	1.86	-	5.93	-	-
P/OCF Ratio	2.43	1.86	-	5.30	-	-
EV/Sales Ratio	0.45	0.86	1.19	1.28	-	3.01
EV/EBITDA Ratio	0.77	1.47	-	-	-	-
EV/EBIT Ratio	0.78	1.48	-	-	-	-
EV/FCF Ratio	0.91	1.73	-	3.24	-	-
Net Debt / Equity Ratio	-1.06	-1.06	-2.70	-1.80	-1.05	-1.00
Net Debt / EBITDA Ratio	-1.29	-1.29	1.41	57.00	0.49	2.84
Net Debt / FCF Ratio	-1.52	-1.52	1.02	-2.45	0.50	1.65
Asset Turnover	1.87	1.87	1.27	1.04	0.00	0.62
Quick Ratio	7.60	7.60	1.14	1.67	3.78	8.74
Current Ratio	7.60	7.60	1.14	1.67	3.78	8.74
Return on Equity (ROE)	142.84%	142.84%	-98.67%	-1.57%	-122.00%	-63.02%
Return on Assets (ROA)	68.05%	68.05%	-22.46%	-1.66%	-65.01%	-28.29%
Return on Capital Employed (ROCE)	81.60%	81.60%	-202.40%	-4.80%	-215.00%	-36.10%
Earnings Yield	45.28%	59.14%	-16.55%	-0.36%	-273.08%	-13.13%
FCF Yield	41.19%	53.79%	-22.32%	16.85%	-268.02%	-22.41%
Buyback Yield / Dilution	-34.07%	-34.07%	-0.01%	-65.98%	-45.85%	-71.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.